Health CanadaGeneral Alert
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat...
Published: October 27, 2020Recall ID: 61776Category: generalCountry: Canada
Product Description & Identification
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
Additional Source Details
| Field | Value |
|---|---|
| N I D | 61776 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/leo-pharma-inc-withdrawing-drug-picato-ingenol-mebutate-used-treat-skin-lesions-due |
| Title | LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2020-10-27 |
| Organization | Communications and Public Affairs Branch |